http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011116139-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_118776bdfdb9ed24170db1f30661daa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cabb29369bfab86360e6d518d1172e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a22e07ca1f2ff37f7e2ff3e596ce0d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56c87f632f1262fc0b7f46a8d4c835e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82436681a77cdb7e9ba3bd6e69fee124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c5beada7373c31322a93f74adf2345c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cac8f844dc6073d004a08564feed2eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_817e18203ad5e6a3a85a5194f9a833a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f82d50a627a96beb3be85fddd72ac80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc2c30c1426afd755fe9af68cba24b29
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc5c0dfa313ced648f13b59f1d3067e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f912e433f383f46b1fd9ef069cf62f07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c03ed79c27fcefb3f40a399c57dcbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b214b895d67a01420ee46285d0bbf18b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b31146dbcaec9ea2fa00c8b6ad9f744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_606a41cb45a7aafcdb8aace2ef614ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_707ba6dc3b473c43cab8641beb20584e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0728e3a59e02d939366ec63f0d227fc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1748271f8a88d35131ebcdd95bb7dc9
publicationDate 2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011116139-A3
titleOfInvention Improved pharmaceutical compositions comprising cck- 8 and methods of delivery
abstract The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent (such as CCK-8, octreotide), at least one salt of a medium chain fatty acid, a matrix forming polymer and a hydrophobic (lipophilic) medium. A surfactant may be included in the suspension. The pharmaceutical compositions may be formulated in a capsule or tablet for oral delivery. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed.
priorityDate 2010-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009126132-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010032140-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006097793-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02070546-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007219131-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57181882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399210

Total number of triples: 67.